Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Prostatic Neoplasms 18Neoplasms 9Colonic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Uterine Cervical Neoplasms 4Colorectal Neoplasms 4Uterine Cervical Dysplasia 3Urinary Bladder Neoplasms 3Mouth Neoplasms 3Esophageal Neoplasms 3Carcinoma, Hepatocellular 3Thyroid Nodule 2Thyroid Neoplasms 2Thrombocythemia, Essential 2Testicular Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Oropharyngeal Neoplasms 2Melanoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Glioma 2Gallbladder Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × Watchful Waiting × Clear all
NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
200 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT05898347 2023-06-12

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Oslo University Hospital

Unknown
10 enrolled
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡